Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1186/s13045-017-0541-9
Published Online: 2017-12-01
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Bingshan
Song, Yongping
Liu, Delong https://orcid.org/0000-0003-4502-4949
Funding for this research was provided by:
National Natural Science Foundation of China (NSFC grant no. 81470287, YPS)
